Latest Breaking News On - Company or revelation - Page 9 : comparemela.com

Revelation Biosciences Inc Announces Closing of $5 Million Public Offering

Revelation Biosciences Inc Announces Closing of $5 Million Public Offering
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNewport beachSandra vedrickviceCompany contactsInvestor relations human resourcesrevelation biosciences incCompany or revelationExchange commissionRevelation biosciences incRoth capital partnersChester zygmont iiichief financial officerrevelation biosciences incWall streetCapital partnersClemente driveMedworld advisorsPrivate securities litigation reform actVedrickvice president

Revelation Biosciences (REVB) Prices 8 33M Share Offering at $0 60/sh

Revelation Biosciences (REVB) Prices 8 33M Share Offering at $0 60/sh
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNewport beachSandra vedrickExchange commissionCompany or revelationCompany contactsRevelation biosciences incRoth capital partnersWall streetCapital partnersClemente driveMedworld advisorsPrivate securities litigation reform actInvestor relations

Revelation Biosciences Inc Announces Pricing of $5 Million Public Offering

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesNewport beachSandra vedrickExchange commissionCompany or revelationCompany contactsRevelation biosciences incRoth capital partnersCapital partnersClemente driveMedworld advisorsPrivate securities litigation reform actInvestor relationsCovid 19Globe newswire

Revelation Biosciences Inc Announces Topline Data for Phase 1b CLEAR Clinical Study of REVTx-99b for the Treatment of Allergic Rhinitis

23.07.2022 - SAN DIEGO, July 22, 2022 (GLOBE NEWSWIRE) - Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on the development of immunologic‑based therapies for the prevention and . Seite 1

Company or revelationRevelation biosciences incRevelation biosciencesAnnounces topline dataAllergic rhinitisTotal nasal symptom scoreMedworld advisors

Revelation Biosciences Inc Announces Topline Data for Phase 1b CLEAR Clinical Study of REVTx-99b for the Treatment of Allergic Rhinitis

Revelation Biosciences Inc Announces Topline Data for Phase 1b CLEAR Clinical Study of REVTx-99b for the Treatment of Allergic Rhinitis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Sandra vedrickviceCompany or revelationCompany contactsRevelation biosciences incInvestor relations human resourcesrevelation biosciences incChester zygmont iiichief financial officerrevelation biosciences incTotal nasal symptom scoreMedworld advisorsPrivate securities litigation reform actVedrickvice presidentInvestor relationsHuman resourcesrevelation biosciencesFinancial officerrevelation biosciencesRevelation biosciences